Peer Review History
| Original SubmissionMarch 20, 2025 |
|---|
|
Dear Dr. Pai, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jun 29 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Muhammad Athar, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 3. We note that you have indicated that there are restrictions to data sharing for this study. For studies involving human research participant data or other sensitive data, we encourage authors to share de-identified or anonymized data. However, when data cannot be publicly shared for ethical reasons, we allow authors to make their data sets available upon request. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Before we proceed with your manuscript, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible. Please update your Data Availability statement in the submission form accordingly. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: Page 3, line 84. This dataset seems to be a population based registry, in the sense that all fatalities occurred in the Country are included, But it is not a trauma registry and many information regarding injuries are lacking. There is no selection of major trauma and also minor injuries are included. The only stratification of severity is fatal and non-fatal crash. If this consideration is correct these concepts should be stressed in the text Page 4, line 122. You cannot define with available data injury severity, but only injury fatality Page 7, line 176-187. Data reported in the text are presented in table 2. The text should comment the table without repeating all the data, outlining more important results In the results the weight of injuries of different body region on fatal outcome has been explored in table 2, but only regarding head and neck injuries. It has been showed that chest injuries are important determinant of death in older motorcyclists. From your data is it possible to derive further information about injuries more associated with fatalities? Limitations of the study are addressed, but if injured regions are available some discussion can be added. In general, the paper is interesting with an important population. The limit is that many sanitary data are lacking and results are more oriented toward problems of limited interest for doctors and nurses Reviewer #2: Effects of aging and risk-taking behaviors on fatal injuries among old motorcyclists in Taiwan: evidence from 2011 to 2022 1. Overall Assessment This is a well-structured and important epidemiological study examining the joint effects of aging and risk-taking behaviors (unhelmeted, unlicensed, and drunk riding) on fatal motorcycle injuries among the elderly in Taiwan. The study leverages a large national dataset (n = 338,231), applies sound statistical methods, and provides policy-relevant conclusions. It fills an important gap by specifically targeting very old motorcyclists (≥75 years) and interaction effects with risk-taking behavior. However, several aspects require clarification, deeper analysis, and improved presentation to strengthen the study’s rigor, clarity, and contribution. 2. Strengths • Large sample size from a reliable national database enhances generalizability. • Clear definition of variables and outcome measures. • Use of joint effects models and subgroup analysis is commendable. • Public health and policy relevance is high. • Ethical clarification and transparency about data usage are adequately addressed. 3. Issues a) Clarification of Study Design and Ethics • While the authors corrected the date of data access (from 2023 to 2024), proof of prospective ethical approval before data access must be clear to meet journal standards. Consider appending a dated ethics approval letter. b) Causality Interpretation • While the authors rightly avoid overclaiming causality, the discussion sometimes implies causal links (e.g., "these behaviors were contributors to fatal injuries"). Reword to emphasize association rather than causality. c) Missing Confounders • Some potentially important confounders are not considered: o Vehicle type/power (e.g., electric vs. gas motorbike). o Road condition complexity (e.g., curves, intersections). o Rider comorbidities or medication use, though these may not be available. o Crash partner behavior or demographics—acknowledged as a limitation but deserves stronger discussion. d) Terminology • Avoid using “very old motorcycles” in the abstract (line 32). It should be “very old motorcyclists.” • Use consistent age group terminology: sometimes written as “≥75 years,” sometimes “very old.” Define this clearly early on and use consistently. e) Language and Style • Some phrasing is awkward or grammatically incorrect. For instance: o “This would underscore the importance of tailored interventions among individuals with a combination of 75 years or above and unlicensed riding…” – should be revised for clarity. o “This particular group of motorcyclists are prohibited from riding if they not fitted enough” – should be “...if they are not fit enough.” Suggest proofreading by a native English editor (beyond Wallace Editing) or using a language enhancement tool. c) Figures • Figure 2 and 3 forest plots are mentioned but not included in the PDF (only URLs). o Reviewers need figures embedded or annexed for full appraisal. o Please include sample sizes per subgroup in forest plots. 5. Conclusion and Recommendation This manuscript addresses a timely and critical road safety issue using robust data and appropriate methods. The focus on very old motorcyclists and interaction with behavioral risks is novel. However, moderate revisions are required to improve clarity, statistical transparency, and precision of interpretation. Recommendation: Minor Revision ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Effects of aging and risk-taking behaviors on fatal injuries among old motorcyclists in Taiwan: evidence from 2011 to 2022 PONE-D-25-14406R1 Dear Dr. Pai, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Muhammad Athar, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: All the questions have been addresses and I have no other observations for the manuscript. Although data which were presented and discussed derive from a non-sanitary data base, some interesting information can be obtained Reviewer #2: (No Response) ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Noor Diana Binti Abdul Majid ********** |
| Formally Accepted |
|
PONE-D-25-14406R1 PLOS ONE Dear Dr. Pai, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Muhammad Athar Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .